Here, we have used these Eμ-Myc models to identify two compensatory bypass signalling pathways used by Eμ-Myc lymphomas for continued growth, proliferation and survival in the absence of optimal ATR–CHK1 signalling. This evidence concerns the gene MYC and lymphoma.